Mass General Brigham’s Medline Inc MDLN Stock Holding History

Mass General Brigham’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	68,413 -1,944	-3%	-$78.3K	0.75%	6
2026 Q1	$3.13M	Buy	70,357 +44,063	+168%	+$1.95M	0.67%	6
2025 Q4	$1.1M	Buy	+26,294	New	+$1.11M	0.14%	6

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mass General Brigham's MDLN Position: Q2 2026 in Review

Mass General Brigham reduced its Medline Inc (MDLN) stake by 2.8% in Q2 2026, selling an estimated $78.3K and leaving 68,413 shares worth $2.7M. The position accounts for 0.75% of the portfolio, ranked #6.

Mass General Brigham first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.13M in Q1 2026. 229 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Mass General Brigham held 68,413 shares of Medline Inc worth $2.7M as of Q2 2026.
Mass General Brigham sold 1,944 Medline Inc shares in Q2 2026, an estimated $78.3K.
Medline Inc made up 0.75% of Mass General Brigham's portfolio in Q2 2026, its #6 holding.
Mass General Brigham first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
Mass General Brigham's Medline Inc position peaked at $3.13M in Q1 2026.
229 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Mass General Brigham's 13F filing for Q2 2026, filed 7 Aug 2026.